MYC and cancer: Reciprocally, oncogenic MYC imparts a series of molecular and metabolic dependencies to cells, thus giving rise to cancer‐specific vulnerabilities that may be exploited to obtain synthetic‐lethal interactions with novel anticancer drugs.